Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure
NICE guidance
Summary (source: NICE)
Reference: HTG599
Type: NICE guidance
Published: 24 November 2021
Issued by: National Institute for Health and Care Excellence (NICE)
Full guidance: Read on nice.org.uk →
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure is nice guidance HTG599, issued by the National Institute for Health and Care Excellence (NICE), which produces evidence-based recommendations for health and care in England.
Note: NICE guidance is published under a licence that applies to the UK and does not permit republication of the full text. This page provides the reference and a direct link to the official document. Read the full guidance on nice.org.uk →
Document official
Official summary published by the National Institute for Health and Care Excellence (nice.org.uk), last published 24 November 2021. Indicative information for healthcare professionals — refer to the full document. Reference and link only, per NICE licence.